Credo Technology Falls as Sector Weakness and Selling Overhang Pressure Shares

Credo Technology Group Holding Ltd (CRDO) is down 5.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a mix of broader semiconductor weakness and stock-specific pressure from valuation concerns and recent insider selling activity. There does not appear to be a new company announcement today, so the decline could be because investors are still digesting a rich valuation, softer sentiment across AI-linked chip names, and recent reductions to analyst price targets.

Details:

The company’s most recent quarterly update showed revenue of $479.0 million, up sharply from a year earlier, but second-quarter guidance pointed to revenue of $525 million to $535 million and a GAAP gross margin range below the prior quarter.

A recent quarterly filing showed cash and cash equivalents fell to $466.9 million from $1.16 billion in the prior quarter, largely because of the DustPhotonics acquisition and higher working-capital needs tied to growth.

Recent ownership filings indicate multiple insider sales in late September and early October, adding an overhang for a stock that had already run up significantly earlier in the year.

An analyst recently kept a positive rating but lowered the price target, which can reinforce near-term profit-taking when sentiment across semiconductor shares is already weak.

Sources:

Credo, SEC, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CRDO Insider Trading Activity

$CRDO insiders have traded $CRDO stock on the open market 301 times in the past 6 months. Of those trades, 0 have been purchases and 301 have been sales.

Here’s a breakdown of recent trading of $CRDO stock by insiders over the last 6 months:

CHI FUNG CHENG (Chief Technology Officer) has made 0 purchases and 180 sales selling 427,312 shares for an estimated $88,399,004.
YAT TUNG LAM (Chief Operating Officer) has made 0 purchases and 57 sales selling 361,439 shares for an estimated $77,263,875.
WILLIAM JOSEPH BRENNAN (Pres & Chief Executive Officer) has made 0 purchases and 33 sales selling 86,656 shares for an estimated $14,815,747.
DANIEL W. FLEMING (Chief Financial Officer) has made 0 purchases and 23 sales selling 55,160 shares for an estimated $13,000,005.
JAMES LAUFMAN (Chief Legal Officer, Secretary) has made 0 purchases and 5 sales selling 30,000 shares for an estimated $6,030,575.
CLYDE HOSEIN sold 3,451 shares for an estimated $905,283
SYLVIA ACEVEDO sold 2,208 shares for an estimated $465,888
FARIBA DANESH sold 1,100 shares for an estimated $259,979

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive CRDO Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CRDO Hedge Fund Activity

We have seen 619 institutional investors add shares of $CRDO stock to their portfolio, and 345 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JENNISON ASSOCIATES LLC added 2,408,196 shares (+974.6%) to their portfolio in Q2 2026, for an estimated $654,908,902
WELLINGTON MANAGEMENT GROUP LLP removed 2,066,529 shares (-60.6%) from their portfolio in Q2 2026, for an estimated $561,992,561
BLACKROCK, INC. removed 2,059,560 shares (-10.4%) from their portfolio in Q2 2026, for an estimated $560,097,342
ALLIANCEBERNSTEIN L.P. removed 1,717,449 shares (-86.5%) from their portfolio in Q2 2026, for an estimated $467,060,255
HRT FINANCIAL LP added 1,387,796 shares (+inf%) to their portfolio in Q2 2026, for an estimated $377,411,122
QUBE RESEARCH & TECHNOLOGIES LTD added 1,342,314 shares (+inf%) to their portfolio in Q2 2026, for an estimated $365,042,292
POINT72 ASSET MANAGEMENT, L.P. removed 1,326,467 shares (-17.7%) from their portfolio in Q2 2026, for an estimated $360,732,700

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CRDO Congressional Stock Trading

Members of Congress have traded $CRDO stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CRDO stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 07/02, 06/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CRDO Analyst Ratings

Wall Street analysts have issued reports on $CRDO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Rothschild & Co issued a "Buy" rating on 05/01/2026

To track analyst ratings and price targets for $CRDO, check out Quiver Quantitative's $CRDO forecast page.

$CRDO Price Targets

Multiple analysts have issued price targets for $CRDO recently. We have seen 13 analysts offer price targets for $CRDO in the last 6 months, with a median target of $270.0.

Here are some recent targets:

Vivek Arya from B of A Securities set a target price of $340.0 on 06/23/2026
Tore Svanberg from Stifel set a target price of $350.0 on 06/22/2026
Mark Lipacis from Evercore ISI Group set a target price of $325.0 on 06/22/2026
N. Quinn Bolton from Needham set a target price of $275.0 on 06/02/2026
Vijay Rakesh from Mizuho set a target price of $290.0 on 06/02/2026
Mike Genovese from Rosenblatt set a target price of $215.0 on 06/02/2026
Blayne Curtis from Jefferies set a target price of $270.0 on 06/02/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.